On Friday, Olema Pharmaceuticals Inc (NASDAQ: OLMA) was 5.94% up from the session before settling in for the closing price of $4.21. A 52-week range for OLMA has been $2.86 – $16.62.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
When this article was written, the company’s average yearly earnings per share was at 12.18%. With a float of $52.12 million, this company’s outstanding shares have now reached $68.33 million.
Considering the fact that the conglomerate employs 96 people, you should pay attention to its efficiency factor. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Olema Pharmaceuticals Inc (OLMA) Breakdown of a Key Holders of the stock
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Olema Pharmaceuticals Inc stocks. The insider ownership of Olema Pharmaceuticals Inc is 23.83%, while institutional ownership is 79.44%. The most recent insider transaction that took place on Jan 08 ’25, was worth 1,727,370. In this transaction 10% Owner of this company bought 300,000 shares at a rate of $5.76, taking the stock ownership to the 7,800,000 shares. Before that another transaction happened on Dec 17 ’24, when Company’s Director sold 700,761 for $6.75, making the entire transaction worth $4,730,137. This insider now owns 0 shares in total.
Olema Pharmaceuticals Inc (OLMA) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around 12.18% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 6.25% during the next five years compared to -83.00% drop over the previous five years of trading.
Olema Pharmaceuticals Inc (NASDAQ: OLMA) Trading Performance Indicators
You can see what Olema Pharmaceuticals Inc (OLMA) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 15.22.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.95, a number that is poised to hit -0.43 in the next quarter and is forecasted to reach -2.18 in one year’s time.
Technical Analysis of Olema Pharmaceuticals Inc (OLMA)
Compared to the last year’s volume of 0.98 million, its volume of 1.26 million showed improvement in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 23.03%. Additionally, its Average True Range was 0.42.
During the past 100 days, Olema Pharmaceuticals Inc’s (OLMA) raw stochastic average was set at 41.64%, which indicates a significant increase from 32.60% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 101.79% in the past 14 days, which was higher than the 78.42% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $4.48, while its 200-day Moving Average is $7.53. Nevertheless, the first resistance level for the watch stands at $4.63 in the near term. At $4.81, the stock is likely to face the second major resistance level. The third major resistance level sits at $5.02. If the price goes on to break the first support level at $4.24, it is likely to go to the next support level at $4.03. Now, if the price goes above the second support level, the third support stands at $3.85.
Olema Pharmaceuticals Inc (NASDAQ: OLMA) Key Stats
There are 68,421K outstanding shares of the company, which has a market capitalization of 305.16 million. As of now, sales total 0 K while income totals -129,470 K. Its latest quarter income was 0 K while its last quarter net income were -30,390 K.
